Patient Case Study: This is my AML Journey – Adam Claxton
I am Adam Claxton and this is my AML Journey
Every single penny raised and donated to Cure Leukaemia goes straight back into funding clinical trials and research, through the Trials and Acceleration Programme (TAP).
The aim of these clinical trials is to not only find better, more effective, and kinder treatments for leukaemia, but it also connect patients to potentially life-saving treatments.
With donations and funding, clinical trials can work to create better treatment for blood cancer patients.
In the UK, someone is diagnosed with blood cancer every 14 minutes.
There are currently 250,000 people living with blood cancer in the UK.
There’s plenty of other ways to get involved and help – from fundraising on your own, to taking part in one of our events.
I am Adam Claxton and this is my AML Journey
From 1986 to Today: A Survivor's Journey with Acute Lymphoblastic Leukaemia
JMW Solicitors Becomes First North West Business to join Club 10
James was diagnosed with Mixed-phenotype acute leukaemia when he was 1 years old.